5-Fluoro-2-hydrazinylpyridine dihydrochloride, 95.0%, 5g

N-(2-Chlorophenyl)methanesulfonamide, 98%, 1g

2,5-Dioxopyrrolidin-1-yl 4-fluorobenzoate, 95.0%, 1g

2,4,7-Trichlorobenzo[d]thiazole, 95.0%, 500mg

Fmoc-(R)-3-Amino-4-(4-nitro-phenyl)-butyric acid, 97%, 1g

5-Fluoro-1-benzothiophene-2-carboxylic acid, 96.0%, 5g

6-Methyl-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 1g

1,2,3,5-TETRA-O-BENZOYL-2-C-METHYL-BETA-D-RIBOFURANOSE, 95%, 10g

2-(TERT-BUTOXYCARBONYL)ISOINDOLINE-5-CARBOXYLIC ACID, 95.0%, 100mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 30 m, Ø-Innen 0,53 mm, Filmd. 2,00 µm, 1 Stück

2-{3-oxo-2h,3h-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetonitrile, 95%, 100mg

8-Amino-4-hydroxynaphthalene-2-sulfonic acid, 98%, 25g

(R)-tert-Butyl 3-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95%, 250mg